Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Hyperthermia × Oxaliplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 38 Pancreatic Neoplasms 27 Stomach Neoplasms 20 Rectal Neoplasms 20 Colonic Neoplasms 16 Esophageal Neoplasms 11 Neoplasm Metastasis 7 Lymphoma, Large B-Cell, Diffuse 7 Gastrointestinal Neoplasms 7 Ovarian Neoplasms 6 Esophageal Squamous Cell Carcinoma 5 Carcinoma, Non-Small-Cell Lung 5 Biliary Tract Neoplasms 5 Adenocarcinoma Of Esophagus 5 Liver Neoplasms 4 Cholangiocarcinoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia 3 Gallbladder Neoplasms 3 Endometrial Neoplasms 3 Advanced Solid Tumors 3 Advanced Solid Tumor 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Leukemia, Prolymphocytic 2 Glioblastoma 2 Gastrointestinal Diseases 2

Interventions

Diathermy 2 tislelizumab 1 spartalizumab 1 Radiotherapy 1 Oxaliplatin 1 Immune Checkpoint Inhibitors 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01716949 2017-08-11

HyRec

University of Erlangen-Nürnberg Medical School

Phase 1/2 Unknown

Gastrointestinal

Hyperthermia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡